This week on Dr. Simpson Unfiltered, we lead with the Ebola outbreak in Central Africa and ask a larger question: why do we spend billions preparing for public health emergencies if we’re reluctant to use the systems we built? Dr. Simpson examines the U.S. response, the controversy over a proposed Ebola facility in Kenya, and why specialized biocontainment units at places like Emory and Nebraska exist for moments exactly like this.
Also this week: an experimental gene-editing treatment that may permanently lower LDL cholesterol after a single infusion, new evidence suggesting long COVID may be far more common than official estimates, the FDA’s review of reports of child deaths following COVID vaccination, and research showing that better cardiovascular health is associated with lower risk of severe COVID infection.
From outbreak preparedness to cutting-edge genetic medicine, Dr. Simpson separates evidence from headlines and explains what these stories mean for patients, physicians, and the future of public health.
Data beats dogma.
